Kevin Dispensa never planned to run a marathon. But when his best friend from high school, Ross, suggested they tackle the Chicago Marathon in honor of Kevin’s mom, Janie Gobeli, everything clicked. Now, Kevin, his brother, his dad, and three …
July 2026 Foundation eNews
Kravitz Krew is going 22-years strong at the ALS Walk for Life For Gary Kravitz, the ALS Walk for Life is a tradition over two decades in the making. Since his first Walk at Montrose Harbor in 2004, Gary and …
Finding the exact target for potential ALS drug
More than 15 years ago, Northwestern University professor Richard Silverman set out to discover a small molecule compound that could prevent toxic protein aggregation in the brain. From that journey came NU-9, a drug that prevents the aggregation of the …
June 2026 Foundation eNews
Unite with us along the lakefront for a world free from ALS Join us at Soldier Field on Saturday, Oct. 24, for the ALS Walk for Life — the largest ALS walk in the Midwest. Registration is officially open, and …
Researchers discover cause of neuron excitability in ALS, leading to new potential treatment
Digging deep into the molecular mechanisms behind ALS, researchers at the Les Turner ALS Center at Northwestern Medicine have discovered why nerve cells overfire in the disease. Not only that—they have also designed a new drug to stop this overfiring, …
June 2026 Foundation eNews
You helped us raise awareness all May With ALS Awareness Month coming to a close at the end of last month, we wanted to acknowledge once more the community members who made these videos possible. Throughout the month, we focused …
May 2026 Foundation eNews
Help us share stories from our community This May, we’re continuing to illuminate the realities of the disease to foster deeper understanding and spark change. Throughout ALS Awareness Month, the focus is on the financial impact, the diagnostic journey, the …
ALS is driven by a domino‑like chain reaction that begins in nerve cells
Study links TDP‑43 pathology to inflammation, disease progression and survival across ALS subtypes. Study used cutting-edge techniques to analyze blood, spinal cord samples from hundreds of patients Immune signatures differ by ALS type (genetic or non-genetic), disease stage, speed of …
Clinical trials test potential new gene therapies for inherited ALS
As director of the clinical research program at the Les Turner ALS Center at Northwestern Medicine, Senda Ajroud-Driss has seen her share of potential ALS therapies. Though many drugs have not made it past clinical trials, recent advances have given …
May 2026 Foundation eNews
Voices and visions for ALS Awareness Month This May, we’re highlighting the profound realities of the disease to foster deeper understanding and drive meaningful change. Throughout the month, we’re focusing on the significant financial impact, the complex diagnostic journey, the …










